MAI Capital Management’s NeuroOne Medical Technologies NMTC Stock Holding History

MAI Capital Management’s Portfolio NMTC Stock Details NMTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-8,333	Closed	-$37.9K	–	5103
2025 Q4	$37.9K	Hold	8,333	–	–	﹤0.01%	2169
2025 Q3	$44.4K	Hold	8,333	–	–	﹤0.01%	2002
2025 Q2	$33.9K	Hold	8,333	–	–	﹤0.01%	2080
2025 Q1	$42.5K	Hold	8,333	–	–	﹤0.01%	1830
2024 Q4	$41.3K	Hold	8,333	–	–	﹤0.01%	1874
2024 Q3	$49.5K	Hold	8,333	–	–	﹤0.01%	1054
2024 Q2	$40K	Hold	8,333	–	–	﹤0.01%	1206
2024 Q1	$60K	Hold	8,333	–	–	﹤0.01%	1178
2023 Q4	$79K	Hold	8,333	–	–	﹤0.01%	1061
2023 Q3	$44.5K	Hold	8,333	–	–	﹤0.01%	1019
2023 Q2	$60K	Hold	8,333	–	–	﹤0.01%	1014
2023 Q1	$80.5K	Hold	8,333	–	–	﹤0.01%	993
2022 Q4	$60K	Hold	8,333	–	–	﹤0.01%	967
2022 Q3	$85K	Buy	+8,333	New	+$79.2K	﹤0.01%	889

Other funds holding NMTC

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

EIM

Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

MAI Capital Management's NMTC Position: Q1 2026 in Review

MAI Capital Management sold out of NeuroOne Medical Technologies (NMTC) in Q1 2026, closing a stake of 8,333 shares — an estimated $37.9K sold.

MAI Capital Management first reported a position in NMTC in Q3 2022 and held it in 14 quarters. The position peaked at $85K in Q3 2022. 32 funds tracked by Wall St. Rank hold NMTC as of Q1 2026.

MAI Capital Management reported no remaining NeuroOne Medical Technologies position as of Q1 2026 after selling out during the quarter.
MAI Capital Management sold 8,333 NeuroOne Medical Technologies shares in Q1 2026, an estimated $37.9K.
MAI Capital Management first reported a position in NeuroOne Medical Technologies in Q3 2022 and held it in 14 quarters.
MAI Capital Management's NeuroOne Medical Technologies position peaked at $85K in Q3 2022.
32 funds tracked by Wall St. Rank held NeuroOne Medical Technologies as of Q1 2026.

Based on MAI Capital Management's 13F filing for Q1 2026, filed 15 May 2026.